Clinical Trial Update: Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating cell therapy for nonrevascularizable critical limb ischemia of the lower limbs. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Nonrevascularizable Critical Ischemia of the Lower Limbs | Phase 1, Phase 2 | Status: COMPLETED